Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-03-08, Stock:PFE, The news for the past five days is as follows:
2021-03-01: NEWS1: Novavax CEO on COVID-19 vaccine trial progress.NEWS2: JNJ Stock Rises In Buy Zone As U.S. Begins Distributing Third Covid Vaccine.NEWS3: Vaccine Acceptance Rises As Americans Eye Covid Mutations: IBD/TIPP Poll.NEWS4: France eases ban on AstraZeneca vaccine for over-65s.NEWS5: Israel to start vaccinating those who recovered from COVID-19.NEWS6: Citi, BofA Jump as Mayo Asks ‘What’s Not to Like’ at Big Banks?.NEWS7: UPDATE 2-UK finds vaccines 80% effective at preventing hospitalisations in over-80s.NEWS8: J&J CEO: 'We're doing this for the long run'.NEWS9: J&J to roll-out single-shot COVID-19 vaccine this week.NEWS10: J&J CEO says Americans should start getting single-dose COVID vaccine within 48 hours.NEWS11: Johnson & Johnson’s Vaccine Will Start Arriving on Tuesday.NEWS12: FDA Emergency Nod for J&J COVID-19 Vaccine Heats Up Competition.NEWS13: Fauci Urges Americans to Take Johnson & Johnson Vaccine Despite Concerns.NEWS14: J&J’s Covid-19 Vaccine Is Authorized. Here’s What It Means for the Stock..NEWS15: Flowserve supplying pumps, valves for Pfizer vaccine production.NEWS16: UPDATE 1-Flowserve supplying pumps, valves for Pfizer vaccine production.NEWS17: South Africa Variant Flummoxes AstraZeneca Vaccine; Is AZN Stock A Buy?.NEWS18: INSIGHT-Amid scramble for COVID-19 vaccine, Latin America turns to Russia.NEWS19: Montreal's Olympic Stadium opens to vaccinating elderly as Canada plays catch-up.NEWS20: Johnson & Johnson Shares Leap After FDA, CDC Coronavirus Vaccine Approvals.NEWS21: France lifts restrictions on giving Oxford/AstraZeneca jab to over-65s.NEWS22: Boris Johnson defends UK border regime amid hunt for Covid patient.
2021-03-02: NEWS1: Merck Stepping In To Help JNJ With Covid Vaccine In 'Wartime Effort'.NEWS2: Merck Reportedly Steps In To Help J&J Manufacture Its Covid Vaccine.NEWS3: Doctor endorses J&J's COVID-19 shot, all 3 vaccines a 'path to ending the pandemic'.NEWS4: Merck, J&J Reportedly Forge Covid Vaccine Alliance — Here's What You Need To Know.NEWS5: Doctor: Even as vaccines progress ‘we can’t let our guard down’.NEWS6: J&J single-dose vaccine is 'absolutely' a game changer: physician.NEWS7: 25 stocks of companies backed by rapid earnings growth as the economy reopens.NEWS8: Renishaw shares soar 18% as engineer puts itself up for sale.NEWS9: Coronavirus update: Merck to produce J&J vaccines; CDC launches vaccine finder.NEWS10: Merck Will Help Make J&J’s Covid-19 Vaccine, Washington Post Reports.NEWS11: AstraZeneca’s Vaccine Works in Older Adults, UK Says.NEWS12: U.S. COVID vaccine supply to be boosted by Merck helping make J&J vaccine.NEWS13: People Allergic To Pfizer, Moderna COVID-19 Vaccine Might Be Allowed To Get JNJ Shot: CNBC.NEWS14: UPDATE 1-France uses only quarter of Astrazeneca vaccine doses-ministry.NEWS15: Where Will Pfizer Be in 1 Year?.NEWS16: Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by more than 80%, study shows.NEWS17: The Zacks Analyst Blog Highlights: Johnson & Johnson, Pfizer, BioNTech, Moderna and AstraZeneca.NEWS18: Strata Oncology Announces the Strata PATH Trial with Pfizer as First Pharma Partner.NEWS19: Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use.NEWS20: UPDATE 1-Woman dies from brain haemorrhage in Japan days after vaccine, but link uncertain.NEWS21: Could Coronavirus Variants Boost Pfizer's Vaccine Sales By 50%?.NEWS22: UPDATE 1-France changes tack and approves AstraZeneca shots for under-75s.NEWS23: AstraZeneca, Pfizer/BioNtech Single Shot COVID-19 Jab 80% Effective At Preventing Hospitalizations In Elderly.NEWS24: UPDATE 1-UK rollout data on AstraZeneca shot should guide other countries -vaccine chief.NEWS25: UPDATE 2-Croda pins Life Science sales boost on Pfizer vaccine deal.NEWS26: S.Korea says up to medical personnel to extract extra doses of COVID vaccine from vial.NEWS27: UPDATE 1-Fauci says U.S. must stick to two-shot strategy for Pfizer, Moderna COVID-19 vaccines - paper.NEWS28: Novavax Hopes to Start Supplying Covid Shots This Spring.
2021-03-03: NEWS1: King Arthur Baking Company sees flour sales up 58% year-over-year amid pandemic.NEWS2: COVID SCIENCE-T cell response to virus variants remains potent; Asthma does not raise severe COVID-19 risk.NEWS3: Senate expected to begin stimulus debate today.NEWS4: Doctor: Health care workers are ‘frustrated and concerned’ over lifting of virus mandates.NEWS5: UPDATE 1-Faster vaccination needed in Latam to curb rise of dangerous variants, PAHO says.NEWS6: Novavax Under Pressure As It Guides To Vaccine Data; Is NVAX Stock A Buy?.NEWS7: Cramer Advises Viewers On Palo Alto, Pfizer, Zillow And More.NEWS8: Analyzing Pfizer's Unusual Options Activity.NEWS9: U.S. Vaccine Shortage Could Soon End With Oversupply.NEWS10: Biden Says U.S. Could Have Enough Vaccine Doses for Every American in May.NEWS11: EU regulator not budging on vaccine dosage as states scramble for shots.NEWS12: EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters.NEWS13: AbbVie Posts A Massive Growth Quarter — Is It Time To Add AbbVie Stock?.NEWS14: Here's What the FDA Liked About Johnson & Johnson's COVID Vaccine.NEWS15: Interim UK study finds one dose of COVID shots reduces hospitalisation.NEWS16: 'Mad Money' Lightning Round: Oracle, Zillow, Pfizer and more.NEWS17: UPDATE 2-S.Korea investigates deaths of two who received AstraZeneca COVID-19 vaccine.
2021-03-04: NEWS1: UPDATE 2-Israel, Austria and Denmark establish vaccine-supply alliance.NEWS2: Novartis Will Help Manufacture CureVac’s Covid-19 Vaccine.NEWS3: Biotech current stock performance is ‘actually pretty rational’: analyst.NEWS4: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS5: Pfizer's (PFE) Lorbrena Gets FDA Nod for First-Line Lung Cancer.NEWS6: Study Reports Some Cases Of Delayed Rash After Moderna COVID-19 Vaccine Dose: Report.NEWS7: The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company.NEWS8: UPDATE 2-Germany approves AstraZeneca for over-65s, extends gap between doses.NEWS9: Pfizer's Lorbrena Wins Full FDA Approval As First Line Treatment Of ALK-Positive Lung Cancer.NEWS10: How Will Johnson & Johnson's COVID Vaccine Shake Up the Market?.NEWS11: UK regulator says will fast-track vaccines for coronavirus variants.NEWS12: U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer.
2021-03-05: nan

Answer: Decrease